News and Announcements

Antipsychotic Combinations vs. Monotherapy in Schizophrenia: A Meta-Analysis of Randomized Controlled Trials

Guideline Recommendations for the Diagnosis and Treatment of Adult ADHD without Comorbidity

Get the latest updates from the Agency for Health Care Administration on information regarding mental health drugs.

Zyprexa has been approved (12-4-09) for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder.

The FDA has approved the use of SEROQUEL in children and adolescents.

Florida Medicaid Drug Therapy Management Program for Behavioral Health in collaboration with Access Health in Pensacola, FL presented to an audience of mental health clinicians a program entitled “At the Crossroads of Medicine and Policy: Psychotherapeutic Medications for Children.”

In July of 2009, the Florida Drug Therapy Management Program for Behavioral Health convened a panel of national experts and Florida mental health clinicians to update the Florida Best Practice Medication Guidelines for Adults.

Effective April 25th, 2008, Medicaid will require a prior authorization for atypical anti-psychotics for children under the age of six years.

AHCA Areas 1, 2a + 2b, 3a and 3b: 1-877-506-2720 AHCA Areas 4, 5, 6, 7 and 8: 1-866-487-9507 AHCA Areas 9, 10, and 11: 1-877-486-3783

Recommended doses for ziprasidone for children 6-11 and 12-17

Mental Health Association of Broward County

Effective September 1st, 2011 Medicaid will require that a Psychotherapeutic Consent Form accompany any new prescription for a psychotherapeutic medication prescribed for children from birth through the 13th birthday.